CAMP4 Therapeutics Corporation Derivative Liability, Noncurrent
CAMP4 Therapeutics Corporation (CAMP) had Derivative Liability, Noncurrent of $71.88 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Derivative Liability, Noncurrent $71.88M.
- 2026-03-31: Derivative Liability, Noncurrent $50.95M.
- 2025-12-31: Derivative Liability, Noncurrent $44.76M.
- 2025-09-30: Derivative Liability, Noncurrent $16.73M.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $71.88M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $50.95M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $44.76M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $16.73M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | $2.00K 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |